Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice
- 15 May 2024
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 15 (2) , 609-620
Abstract
Vaginal atrophy affects up to 57% of post-menopausal women, with symptoms ranging from vaginal burning to dysuria. Estradiol hormone replacement therapy may be prescribed to alleviate these symptoms, though many vaginal products have drawbacks including increased discharge and local tissue toxicity due to their hypertonic nature. Here, we describe the development and characterization of a Pluronic F127-coated estradiol nanosuspension (NS) formulation for improved vaginal estradiol delivery. We compare the pharmacokinetics to the clinical comparator vaginal cream (Estrace) and demonstrate increased delivery of estradiol to the vaginal tissue. We utilized ovariectomized (OVX) mice as a murine model of post-menopausal vaginal atrophy and demonstrated equivalent efficacy in vaginal re-epithelialization when dosed with either the estradiol NS or Estrace cream. Further, we demonstrate compatibility of the estradiol NS with vaginal bacteria in vitro. We demonstrate that a Pluronic F127-coated estradiol NS may be a viable option for the treatment of post-menopausal vaginal atrophy. Graphical AbstractKeywords
Funding Information
- National Cancer Institute (P30CA006973)
- National Center for Advancing Translational Sciences (UL1TR003098)
- National Center for Research Resources (S10RR026824)
- National Institute of Child Health and Human Development (R01HD103124, R01HD108905)
- National Science Foundation Graduate Research Fellowship Program (National Science Foundation Graduate Research Fellowship Program, National Science Foundation Graduate Research Fellowship Program)
- Hartwell Foundation (Hartwell Foundation)
This publication has 85 references indexed in Scilit:
- In vitro and ex vivo models for evaluating vaginal drug delivery systemsAdvanced Drug Delivery Reviews, 2022
- Women’s preferences and acceptance for different drug delivery routes and productsAdvanced Drug Delivery Reviews, 2022
- Mucus‐Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal SurfacesAdvanced Healthcare Materials, 2016
- First Trimester Levels of BV-Associated Bacteria and Risk of Miscarriage Among Women Early in PregnancyMaternal and Child Health Journal, 2015
- Vaginal Delivery of Paclitaxel via Nanoparticles with Non‐Mucoadhesive Surfaces Suppresses Cervical Tumor GrowthAdvanced Healthcare Materials, 2013
- Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal WomenSexual Medicine, 2013
- Vaginal Films for Drug DeliveryJournal of Pharmaceutical Sciences, 2013
- Age at Natural Menopause and Risk of Cardiovascular DiseaseArchives of internal medicine (1960), 1999
- Clinical trial of the estradiol vaginal ring in the U.S.Maturitas, 1995
- Efficacy of estradiol vaginal cream in postmenopausal womenClinical Pharmacology & Therapeutics, 1979